Both companies have finally broadened their previous contract as a result of promising scientific data from Stage 1/2 trials of Bellicum’s ARGENT-regulated cancers vaccine and cell-therapy product candidates, both utilizing AP1903 to achieve chemical substance induction of dimerization . In the Stage 1/2 trial of sufferers with metastatic castrate-resistant prostate cancer tumor at The University of Texas Health Science Center, Houston, sufferers received the Bellicum immunotherapy followed by AP1903 one day later. Data from the analysis showed that small-molecule regulated immunotherapy was well tolerated and elicited both medical and antigen-specific immune responses in keeping with patient benefit in prostate malignancy.Scientific trials of enzalutamide in earlier-stage prostate malignancy are ongoing. To conclude, enzalutamide significantly prolonged survival in men with metastatic castration-resistant prostate cancer following chemotherapy.
Advanced imaging algorithm produces clearer ultrasound images University of Virginia Engineering College Associate Professor William F. Together with graduate college student Michael A. Ellis, biomedical engineering group has created a novel way of signal processing which you can use with a broad range of imaging and sensing systems including ultrasound, RADAR, SONAR, telecommunications, and even a few optical imaging systems.